CurveBeam AI Limited (ASX:CVB – Get Free Report) insider Robert Lilley purchased 250,000 shares of the company’s stock in a transaction on Friday, December 6th. The shares were purchased at an average price of A$0.12 ($0.08) per share, for a total transaction of A$29,750.00 ($18,949.04).
CurveBeam AI Price Performance
About CurveBeam AI
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe and North America. The company builds artificial intelligence tools to aid in bone separation and segmentation, empowering orthopedic surgeons to make 3D-based deformity measurements to inform clinical decisions.
Read More
- Five stocks we like better than CurveBeam AI
- Investing in Commodities: What Are They? How to Invest in Them
- The Great CPU Race: AMD and Intel Battle for Dominance
- What is Put Option Volume?
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- Do ETFs Pay Dividends? What You Need to Know
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for CurveBeam AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CurveBeam AI and related companies with MarketBeat.com's FREE daily email newsletter.
